Adrenoleukodystrophy clinical trials

Explore recruiting adrenoleukodystrophy clinical trials.

Recruiting adrenoleukodystrophy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adrenoleukodystrophy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE 1, OPENLABEL, SINGLECENTER STUDY TO EVALUATE DRUGDRUG INTERACTIONS WITH GEMFIBROZIL, ITRACONAZOLE, AND CARBAMAZEPINE AND THE FOOD-EFFECT ON ORAL LERIGLITAZONE IN MALE HEALTHY SUBJECTS

Poland

Human Pharmacology (Phase I)- Other EU CTIS Study details

A CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF LERIGLITAZONE IN ADULT MALE SUBJECTS WITH CEREBRAL ADRENOLEUKODYSTROPHY

Spain, Germany, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

AN OPEN-LABEL, MULTICENTER STUDY IN MALE PEDIATRIC PATIENTS WITH CEREBRAL X-LINKED ADRENOLEUKODYSTROPHY (CALD) TO ASSESS THE EFFECTS OF MIN-102 TREATMENT ON DISEASE PROGRESSION PRIOR TO HUMAN STEM CELL TRANSPLANT (HSCT)

Germany, France, Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Longterm Follow-up of Subjects with Cerebral Adrenoleukodystrophy Who Were Treated with Lenti-D Drug Product

France, Germany, Italy, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Treating Leg Symptoms in Women with X-linked Adrenoleukodystrophy: A Key to Improving Sleep and Gait Performance

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Adrenoleukodystrophy trials by city

Adrenoleukodystrophy in Toronto Adrenoleukodystrophy in Vancouver Adrenoleukodystrophy in Montreal Adrenoleukodystrophy in Calgary Adrenoleukodystrophy in Edmonton Adrenoleukodystrophy in Ottawa Adrenoleukodystrophy in Winnipeg Adrenoleukodystrophy in Quebec City Adrenoleukodystrophy in Hamilton Adrenoleukodystrophy in Kitchener Adrenoleukodystrophy in London Adrenoleukodystrophy in Halifax Adrenoleukodystrophy in New York Adrenoleukodystrophy in Los Angeles Adrenoleukodystrophy in Chicago Adrenoleukodystrophy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease